Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience

Danielle El-Haddad, Firas El Chaer, Jackapat Vanichanan, Dimpy P. Shah, Ella J. Ariza-Heredia, Victor E. Mulanovich, Alison M. Gulbis, Elizabeth J. Shpall, Roy F. Chemaly

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint Dive into the research topics of 'Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience'. Together they form a unique fingerprint.

Medicine & Life Sciences